The Exchange has decided to halt the trading in the shares of Immune Pharmaceuticals Inc. (IMNP, ISIN code US45254C2008, order book ID 032838) until further notice.
For further information concerning this exchange notice please contact Joakim Strid or Carl Barbäck, telephone +46 8 405 60 00.